PUBLISHER: DataM Intelligence | PRODUCT CODE: 1319141
PUBLISHER: DataM Intelligence | PRODUCT CODE: 1319141
Global Autotransfusion System Market reached US$ 321.4 million in 2022 and is expected to reach US$ 482.6 million by 2030 growing with a CAGR of 5.3% during the forecast period 2023-2030.
Autotransfusion is a process wherein a person receives their own blood for a transfusion instead of banked allogenic (separate-donor) blood. The goal of autotransfusion remains the same, to maintain a sterile field, prevent clotting of the collected blood, filtration of the blood, and administration to the patient.
The major factor that is driving the autotransfusion market is the increase in the number of vascular surgeries. A number of people are suffering from vascular diseases, which are leading to autotransfusion treatment in order to avoid rejection.
For instance, according to the Journal of Vascular Surgery, 107 operations were performed annually. Among the defined cohort of vascular surgeons, 11% performed more than 200 procedures, and 21% performed fewer than 50. On average, 107 vascular procedures were performed annually by a vascular surgeon. Thus, increase in the number of vascular surgeries is increasing the market growth.
The introduction of new technologies and developments in autotransfusion has been the drive for the autotransfusion system market. For instance, in 2022, NIH revealed a study stating that a medical device intended to collect and wash intra-operatively collected blood to obtain a concentrated blood product at the end of the process.
The device integrates an innovative filtration technology through hollow fibers, allowing RBCs concentration but also platelets within the concentrated blood product and contaminant elimination.Thus technological developments havebeen a drive for the autotransfusion system market.
Less number of skilled professionals to perform the autotransfusion system better will decline the growth of the market. As there is an increase in the number of different kinds of surgeries there is a need foran ample number of professionals to treat the patients. Thus reduced count of skilled professionals can decline the market growth.
The COVID-19 pandemic epidemic has had a negative impact on the autotransfusion market. Many of the autotransfusion centers and diagnostic centers were closed, which has affected a large number of patients, and the transfusion rate has declined. The autotransfusion treatments have been postponed, which has created severe health issues This resulted in a significant increase in the number of patients lacking the treatment.
The Russia-Ukraine conflict is estimated to have a moderate impact on the global autotransfusion system market, owing to the low number of key market players in this region. However, the impact of the import and export of raw materials is expected to have little influence over the global autotransfusion system market growth over the forecast period.
The global autotransfusion system market is segmented based on product type, techniques, application, and end user.
Cardiology holds the most significant market share of around 41.7% during the forecast period. Autotransfusion of blood aspirated from the pericardium enables the operator to maintain hemodynamic stability (until surgery can be performed) and attempt to seal the cardiac perforation despite substantial and persistent fluid accumulation.
For instance, according to Lifespan Organization, there are about 500,000 open heart surgeries performed each year. It is most often used for complicated procedures, such as coronary artery bypass, or complex procedures to the aorta or the heart itself. An increase in surgeries required autotransfusion to be raised. Thus, the above factors are influencing the growth of the segment.
Due to the increased cardiac surgeries in this region ,there is an ample need for autotransfusion to be performed. The increase in the requirement for autotransfusion has increased the development of autotransfusion systems which has influenced the growth of the autotransfusion market in these regions.
For instance, according to CDS, 38 900 heart bypasses were conducted in Germany in 2020; this was more than double the number in any of the other EU Member States (16 400 were conducted in France). Hypertension is on the rise in Europe, especially in the rural and urban populations, which is increasing the incidence of cardiac surgeries.
The major global players in the autotransfusion market include: BD, Fresenius Kabi, Zimmer, Armstrong Medical, Beijing ZKSK Technolgy, Haemonetics, LivaNova, Terumo BCT, Atrium Medical Corporation, Medtronic among others.
The global autotransfusion system market report would provide approximately 53 tables, 54 figures, and 195 Pages.
LIST NOT EXHAUSTIVE